Announcement on Departure and Appointment of General Manager
Securities code: 600993 Securities abbreviation: Ma Yinglong Announcement number: 2026-022
Mayinglong Pharmaceutical Group Co., Ltd.
Announcement on the resignation and appointment of the general manager of the company
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Mr. Xia Youzhang applied to resign from the position of general manager of the company due to personal reasons. The board of directors appointed Mr. Zhou Daonian as the general manager of the company. This change will not affect the company's normal operations.
1. Resignation of the general manager of the company
(1) Basic circumstances of early resignation
The board of directors of Mayinglong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") received a written resignation report from Mr. Xia Youzhang on August 24, 2026. Mr. Xia Youzhang applied to resign from the position of general manager of the company due to personal reasons. According to the "Company Law", "Articles of Association" and other relevant regulations, the resignation report will take effect from the date it is delivered to the board of directors. After Mr. Xia Youzhang resigns as general manager, he will continue to serve as the company's director, member of the strategic committee and subsidiary management. The specific circumstances of resignation are as follows:
Whether he continues to serve? Whether he has not left office. When he left office, the original term of office. When he left office, he left office. Specific positions (such as
Name Municipal Company and its Controllers Duty Completed Time Due Date Reason (Applicable)
Holding a position in a joint-stock company Publicly commit to being a director of the company, fighting No, there is no future
2026
General Manager, Board of Directors changed, Personal Strategy Committee Committee member Xia Youzhang completed his duties on August 24 Yes
Reasons for the expiry of the term of office Members and subsidiaries’ public commitments (including date)
Corporate management position (increased holdings commitment)
(2) The impact of resignation on the company
Mr. Xia Youzhang's resignation as the company's general manager will not affect the company's normal operations and the work handover will be carried out in accordance with relevant regulations. The board of directors expresses its gratitude for his efforts during his tenure.
2. Appointment of general manager of the company
In accordance with the relevant provisions of the Company Law, the Articles of Association and other relevant provisions, after being nominated by the chairman of the company and reviewed and approved by the nomination committee of the board of directors, the 26th meeting of the 11th board of directors of the company reviewed and approved the "Proposal on the Appointment of the General Manager of the Company", agreeing to appoint Mr. Zhou Daonian as the general manager of the company, and at the same time remove him from the position of deputy general manager of the company. The term shall be from the date of review and approval by the board of directors to the date of completion of the general election of the company's board of directors.
Announcement is hereby made.
Attachment: Zhou Daonian’s resume
Board of Directors of Mayinglong Pharmaceutical Group Co., Ltd.
Attachment on August 26, 2026: Zhou Daonian’s resume
Mr. Zhou Daonian, born in 1981, holds a PhD in pharmacology. He is currently the deputy general manager of Mayinglong Pharmaceutical Group Co., Ltd. He once served as assistant to the general manager, deputy general manager and general manager of the research and development center of Mayinglong Pharmaceutical Group Co., Ltd., and assistant to the general manager of Mayinglong Pharmaceutical Group Co., Ltd.
As of now, Mr. Zhou Daonian does not hold shares in the company, and has no relationship with shareholders who hold more than 5% of the company's shares, company directors, or other senior managers; there is no situation in which he is not prohibited from serving as a senior manager of a listed company under relevant laws and regulations; there is no situation where the China Securities Regulatory Commission has taken market ban measures that prohibit him from serving as a senior manager of a listed company and the period has not yet expired; there is no situation where he has been publicly determined by the stock exchange to be unsuitable to serve as a senior manager of a listed company and the period has not yet expired; in the recent 36 It has not been subject to administrative punishment by the China Securities Regulatory Commission, public condemnation from the stock exchange, or more than three notices of criticism within three months. It has not been investigated by judicial authorities for suspected crimes or investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations, and no clear conclusion has been reached. There are no bad records such as major breach of trust, etc.